Publicaciones en las que colabora con Miguel Angel Martín Casanueva (21)

2022

  1. Identification of Potential Muscle Biomarkers in McArdle Disease: Insights from Muscle Proteome Analysis

    International Journal of Molecular Sciences, Vol. 23, Núm. 9

  2. Long-Term Exercise Intervention in Patients with McArdle Disease: Clinical and Aerobic Fitness Benefits

    Medicine and science in sports and exercise, Vol. 54, Núm. 8, pp. 1231-1241

  3. Low aerobic capacity in McArdle disease: A role for mitochondrial network impairment?

    Molecular metabolism, Vol. 66, pp. 101648

  4. Preclinical Research in McArdle Disease: A Review of Research Models and Therapeutic Strategies

    Genes, Vol. 13, Núm. 1

2020

  1. Creation and implementation of a European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC registry)

    Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1

  2. Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC)

    Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1

  3. Sex differences and the influence of an active lifestyle on adiposity in patients with mcardle disease

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 12, pp. 1-11

2018

  1. A New Condition in McArdle Disease: Poor Bone Health - Benefits of an Active Lifestyle

    Medicine and Science in Sports and Exercise, Vol. 50, Núm. 1, pp. 3-10

  2. Correction to: Manifesting heterozygotes in McArdle disease: a myth or a reality—role of statins (Journal of Inherited Metabolic Disease, (2018), 41, 6, (1027-1035), 10.1007/s10545-018-0203-2)

    Journal of Inherited Metabolic Disease

  3. Health Benefits of an Innovative Exercise Program for Mitochondrial Disorders

    Medicine and Science in Sports and Exercise, Vol. 50, Núm. 6, pp. 1142-1151

  4. Manifesting heterozygotes in McArdle disease: a myth or a reality—role of statins

    Journal of Inherited Metabolic Disease, Vol. 41, Núm. 6, pp. 1-9

  5. Non-osteogenic muscle hypertrophy in children with McArdle disease

    Journal of Inherited Metabolic Disease, Vol. 41, Núm. 6, pp. 1037-1042

2017

  1. Genotypic and phenotypic features of all Spanish patients with McArdle disease: A 2016 update

    BMC Genomics, Vol. 18

  2. Low versus high carbohydrates in the diet of the world-class athlete: insights from McArdle's disease

    Journal of Physiology

2016

  1. Exercise and preexercise nutrition as treatment for McArdle disease

    Medicine and Science in Sports and Exercise, Vol. 48, Núm. 4, pp. 673-679

  2. Genes and exercise intolerance: Insights from McArdle disease

    Physiological Genomics, Vol. 48, Núm. 2, pp. 93-100

  3. Xanthine oxidase pathway and muscle damage. insights from McArdle disease

    Current Pharmaceutical Design, Vol. 22, Núm. 18, pp. 2657-2663

2015

  1. McArdle Disease: Update of Reported Mutations and Polymorphisms in the PYGM Gene

    Human Mutation, Vol. 36, Núm. 7, pp. 669-678

  2. Report on the EUROMAC McArdle Exercise Testing Workshop, Madrid, Spain, 11-12 July 2014

    Neuromuscular Disorders, Vol. 25, Núm. 9, pp. 739-745

2014

  1. McArdle disease does not affect skeletal muscle fibre type profiles in humans

    Biology Open, Vol. 3, Núm. 12, pp. 1224-1227